<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03618836</url>
  </required_header>
  <id_info>
    <org_study_id>2011_16</org_study_id>
    <secondary_id>2011-A01254-37</secondary_id>
    <secondary_id>PHRC_N 2011N°19-22</secondary_id>
    <nct_id>NCT03618836</nct_id>
  </id_info>
  <brief_title>Study of the Risk of PREMaturité According to the Balance of Bacterial Flora VAginale</brief_title>
  <acronym>PREMEVA2</acronym>
  <official_title>Study of the Risk of PREMaturité According to the Balance of Bacterial Flora VAginale (PREMEVA2)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Lille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective

      To compare vaginal microbiota in the first trimester of pregnancy between spontaneous preterm
      and term deliveries
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Material and methods Case-control study nested in a cohort of pregnant patients in the first
      trimester. Inclusion criteria. : case is defined as spontaneous preterm births between 22 and
      36 weeks in one of the 14 centers. The &quot;control&quot; patient will be considered as the following
      delivery over ≥ 37 weeks in the same center.

      Multiple pregnancies, medical interruptions of pregnancy and deaths in utero will be
      excluded. Regarding the vaginal flora of cases and controls, the microorganisms will be
      researched and quantified by molecular methods.

      Expected results

      Patients and control patients will be compared for their demographic, obstetric, clinical and
      microbiological data. The parameters related to the risk of spontaneous prematurity at the p
      &lt;0.20 threshold will then be analyzed by multi-level logistic regression.

      Implications At a time when the link between bacterial vaginosis and prematurity is
      controversial, the detection - or not - of microorganisms linked to the risk of prematurity
      will be a key issue.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Vaginal Microbiota pattern</measure>
    <time_frame>10 years</time_frame>
    <description>All microorganism potentially present in the vagina</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Vaginal biological pattern</measure>
    <time_frame>10 years</time_frame>
    <description>Biochemical and immunological compounds present in the vagina</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">1000</enrollment>
  <condition>Preterm Birth</condition>
  <arm_group>
    <arm_group_label>Cases. Preterm Births</arm_group_label>
    <description>Microbiological and biological patterns on vaginal samples in the first trimester of pregnancy among spontaneous preterm births between 22 and 36 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls. Term Births</arm_group_label>
    <description>Microbiological and biological patterns on vaginal samples in the first trimester of pregnancy among deliveries over ≥ 37 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Microbiological and biological patterns on vaginal samples</intervention_name>
    <description>To compare the microbiological and biological patterns between groups</description>
    <arm_group_label>Cases. Preterm Births</arm_group_label>
    <arm_group_label>Controls. Term Births</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Vaginal samples with DNA of microorganisms
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Cohort of pregnant patients in the first trimester
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  case: spontaneous preterm births between 22 and 36 weeks in one of the 14 centers

          -  controls : the following delivery over ≥ 37 weeks in the same center

        Exclusion Criteria:

          -  Multiple pregnancies, medical interruptions of pregnancy and deaths in utero
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Damien Subtil, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital Jeanne de Flandres, CHRU</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>August 1, 2018</study_first_submitted>
  <study_first_submitted_qc>August 1, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 7, 2018</study_first_posted>
  <last_update_submitted>August 1, 2018</last_update_submitted>
  <last_update_submitted_qc>August 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Bacterial vaginosis</keyword>
  <keyword>Vaginal microbiota</keyword>
  <keyword>Molecular methods</keyword>
  <keyword>Next generation sequencing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

